Login / Signup
Robert Pirker
ORCID
Publication Activity (10 Years)
Years Active: 2019-2019
Publications (10 Years): 1
Top Topics
Advanced Non Small Cell Lung Cancer
Combination Therapy
Replacement Therapy
Top Venues
ESMO open
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Robert Pirker
,
Martin Filipits
From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer.
ESMO open
4 (5) (2019)